Henderson wants biomedical companies to use his research as a first-of-its-kind discovery to make advancements in treatments for individuals with an organ malfunction.
"Inject it into a person who has a liver malfunction, because of a genetic error," he said, talking about a usage scenario. "The [nanoparticles] go all over the body and attach to the liver, and literally edit their genome in that liver to fix that genetic malfunction."
Henderson's team has shown they can change DNA nanoparticles with a specific genome expression, which contains all of a person's or animal's genetic information, to fix a genetic error.